Expert opinion: metformin in the prevention and treatment of weight gain during antipsychotic drug therapy

Sławomir Murawiec

doi:10.5114/psychs.2024.142281

ISSN: 2720-7048

Psychiatria Spersonalizowana

Current issue Archive Manuscripts accepted About the journal Editorial board Subscription Contact Instructions for authors

Without publication fees

Open access

1-2/2024
vol. 3

Send email

Copy url:

abstract:

Commentary

Expert opinion: metformin in the prevention and treatment of weight gain during antipsychotic drug therapy

Sławomir Murawiec

¹

Prywatna Praktyka Specjalistyczna, Warszawa

Psychiatria Spersonalizowana 2024; 3(1–2): 10-14

DOI: https://doi.org/10.5114/psychs.2024.142281

Online publish date: 2024/08/14

View full text Get citation

PlumX metrics:

The introduction of second-generation antipsychotics into psychiatric practice has been associated with significant advances in treatment options for schizophrenia and other disorders. However, the weight gain associated with the use of this group of drugs is a major limitation to their use and negatively affects patient compliance. As a result, methods have been sought to reduce the impact of this unfavorable factor. This paper reviews the scientific literature on the use of metformin as a method of early intervention (to limit weight gain) and as a method of treating weight gain that has already occurred during antipsychotic drug therapy. The use of metformin can lead to a weight loss of about 3 kg in those being treated and can prevent a weight gain of about 5 kg in those starting treatment.

keywords:

Expert opinion: metformin in the prevention and treatment of weight gain during antipsychotic drug therapy

Sławomir Murawiec 1

antipsychotics, schizophrenia, weight gain, metformin

Sławomir Murawiec

¹